Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism DNM1L modulators(Dynamin like protein 1 modulators), MTFP1 modulators(Mitochondrial fission protein 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | IL | - | |
Huntington Disease | Preclinical | IL | - | |
Parkinson Disease | Preclinical | IL | - |